OPYS Telehealth Blog Series January 6, 2022 Issue No. 2 Anytime you hear or read a healthcare related news story, there seems to be more information about COVID, and the global pandemic that is now approaching the two-year mark. The newest variant gaining traction is called flurona. As you might guess, the term flurona is used when a … [Read more...]
Expanding Telehealth Access – Lessons from Omicron
What are the Data on Ivermectin for COVID-19?
Ivermectin, a medication that has long been approved by the U.S. Food and Drug Administration (FDA) and World Health Organization (WHO) to fight parasites and treat worm infections, has been a topic of controversy during the COVID-19 pandemic. Some experts have argued that public messages about ivermectin could lead people to use ivermectin that is … [Read more...]